UroGen Pharma Ltd. Capital Expenditures
UroGen Pharma Ltd. (URGN) reported Capital Expenditures of $114.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $60.00K, a 57.45% decline year-over-year.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $54.00K, a 22.73% increase year-over-year.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $17.00K, a 85.22% decline year-over-year.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $87.00K, a 9.38% decline year-over-year.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for fiscal 2025 was $289.00K, a 2.03% decline from fiscal 2024.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for fiscal 2024 was $295.00K, a 52.06% increase from fiscal 2023.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for fiscal 2023 was $194.00K, a 23.62% decline from fiscal 2022.
- UroGen Pharma Ltd. payments to acquire property, plant, and equipment for fiscal 2022 was $254.00K, a 66.22% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $114.00K 10-Q · filed 2026-08-05 | $131.00K derived: sum of 3 quarters · filed 2026-08-05 | $218.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $54.00K 10-Q · filed 2026-05-06 | $71.00K derived: sum of 2 quarters · filed 2026-05-06 | $158.00K derived: sum of 3 quarters · filed 2026-05-06 | $299.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $104.00K derived: sum of 2 quarters · filed 2026-03-02 | $245.00K derived: sum of 3 quarters · filed 2026-08-05 | $289.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $228.00K derived: sum of 2 quarters · filed 2026-08-05 | $272.00K 10-Q · filed 2025-11-06 | $387.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $185.00K 10-Q · filed 2026-08-05 | $300.00K derived: sum of 3 quarters · filed 2026-08-05 | $396.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $44.00K 10-Q · filed 2026-05-06 | $159.00K derived: sum of 2 quarters · filed 2026-05-06 | $255.00K derived: sum of 3 quarters · filed 2026-05-06 | $339.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $211.00K derived: sum of 2 quarters · filed 2026-03-02 | $295.00K derived: sum of 3 quarters · filed 2026-03-02 | $295.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $180.00K derived: sum of 2 quarters · filed 2025-11-06 | $180.00K 10-Q · filed 2025-11-06 | $236.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $84.00K 10-Q · filed 2025-08-07 | $140.00K derived: sum of 3 quarters · filed 2025-08-07 | $240.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $56.00K derived: sum of 2 quarters · filed 2025-05-12 | $156.00K derived: sum of 3 quarters · filed 2025-05-12 | $171.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $156.00K derived: sum of 2 quarters · filed 2025-03-10 | $171.00K derived: sum of 3 quarters · filed 2025-03-10 | $194.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $115.00K derived: sum of 2 quarters · filed 2024-11-06 | $138.00K 10-Q · filed 2024-11-06 | $151.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $38.00K 10-Q · filed 2024-08-13 | $51.00K derived: sum of 3 quarters · filed 2024-08-13 | $204.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $23.00K 10-Q · filed 2024-05-13 | $36.00K derived: sum of 2 quarters · filed 2024-05-13 | $189.00K derived: sum of 3 quarters · filed 2024-05-13 | $252.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $166.00K derived: sum of 2 quarters · filed 2024-03-14 | $229.00K derived: sum of 3 quarters · filed 2024-03-14 | $254.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $216.00K derived: sum of 2 quarters · filed 2023-11-14 | $241.00K 10-Q · filed 2023-11-14 | $443.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $88.00K 10-Q · filed 2023-08-10 | $290.00K derived: sum of 3 quarters · filed 2023-08-10 | $484.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $25.00K 10-Q · filed 2023-05-11 | $227.00K derived: sum of 2 quarters · filed 2023-05-11 | $421.00K derived: sum of 3 quarters · filed 2023-05-11 | $490.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $396.00K derived: sum of 2 quarters · filed 2023-03-24 | $465.00K derived: sum of 3 quarters · filed 2023-03-24 | $752.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $263.00K derived: sum of 2 quarters · filed 2022-11-10 | $550.00K 10-Q · filed 2022-11-10 | $722.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $356.00K 10-Q · filed 2022-08-11 | $528.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.19M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $287.00K 10-Q · filed 2022-05-10 | $459.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.12M derived: sum of 3 quarters · filed 2022-05-10 | $1.41M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $832.00K derived: sum of 2 quarters · filed 2022-03-21 | $1.12M derived: sum of 3 quarters · filed 2022-03-21 | $1.22M 10-K · filed 2022-03-21 |
| 2020-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $947.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.04M 10-Q · filed 2021-11-15 | $1.24M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $383.00K 10-Q · filed 2021-08-04 | $575.00K derived: sum of 3 quarters · filed 2021-08-04 | $624.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $96.00K 10-Q · filed 2021-05-13 | $288.00K derived: sum of 2 quarters · filed 2021-05-13 | $337.00K derived: sum of 3 quarters · filed 2021-05-13 | $377.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $241.00K derived: sum of 2 quarters · filed 2021-03-18 | $281.00K derived: sum of 3 quarters · filed 2021-03-18 | $325.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $89.00K derived: sum of 2 quarters · filed 2020-11-09 | $133.00K 10-Q · filed 2020-11-09 | $157.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $84.00K 10-Q · filed 2020-08-10 | $108.00K derived: sum of 3 quarters · filed 2020-08-10 | $440.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $44.00K 10-Q · filed 2020-05-07 | $68.00K derived: sum of 2 quarters · filed 2020-05-07 | $400.00K derived: sum of 3 quarters · filed 2020-05-07 | $532.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $356.00K derived: sum of 2 quarters · filed 2020-03-02 | $488.00K derived: sum of 3 quarters · filed 2020-03-02 | $560.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $332.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $464.00K derived: sum of 2 quarters · filed 2019-11-12 | $536.00K 10-Q · filed 2019-11-12 | $689.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $204.00K 10-Q · filed 2019-08-09 | $357.00K derived: sum of 3 quarters · filed 2020-03-02 | $377.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $72.00K 10-Q · filed 2019-05-09 | $225.00K derived: sum of 2 quarters · filed 2020-03-02 | $245.00K derived: sum of 3 quarters · filed 2020-03-02 | $265.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $153.00K derived: 10-K 12 month − 6-K 9 month · filed 2020-03-02 | $173.00K derived: sum of 2 quarters · filed 2020-03-02 | $193.00K derived: sum of 3 quarters · filed 2020-03-02 | $271.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $20.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | $40.00K derived: sum of 2 quarters · filed 2018-11-13 | $118.00K 6-K · filed 2018-11-13 | |
| 2017-06-30 | $20.00K derived: 6-K 6 month − 6-K 3 month · filed 2018-08-14 | $98.00K 6-K · filed 2018-08-14 | ||
| 2017-03-31 | $78.00K 6-K · filed 2018-05-15 | |||
| 2016-12-31 | $695.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $301.00K 20-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |